摘要:
The present invention relates to the use of the WAP or MMTV regulatory sequences for the targeted expression of linked heterologous DNA sequences in human mammary cells, including human mammary carcinoma cells.
摘要:
The present invention relates to retroviral vectors carrying DNA sequences encoding SDI-1, functional analogues or fragments thereof, or antisense SDI-1 DNA sequences, and especially retroviral vectors carrying SDI-1 or antisense SDI-1 sequences under transcriptional control of target cell specific regulatory elements or promoters or X-ray inducible promoters.
摘要:
The invention refers to novel recombinant vectors useful for gene therapy of viral infections and of diseases associated with B and T cells. The present invention relates, furthermore, to novel usages of the two products of the open reading frame of mouse mammary tumour virus.
摘要:
The present invention relates to encapsulated cells producing viral particles, especially retroviral particles containing the genome of a viral vector carrying therapeutic genes, methods for the preparation of such encapsulated cells, as well as the use of such encapsulated cells for the treatment of diseases.
摘要:
The present invention relates to a retroviral vector system comprising a packaging cell line that synthesize the core and enzymatic proteins of MLV virus from one or more gag and pol containing constructs and the envelope of MMTV virus from the same or an independent env containing construct, and to pseudotyped retroviral particles produced by culturing said retroviral vector system transfected with a MLV based retroviral vector, and isolation of said pseudotyped retroviral particles.
摘要:
The invention refers to novel recombinant vectors useful for gene therapy of viral infections and of diseases associated with B and T cells. The present invention relates, furthermore, to novel usages of the two products of the open reading frame of mouse mammary tumour virus.
摘要:
The present invention relates to a retroviral vector system comprising a packaging cell line that synthesize the core and enzymatic proteins of MLV virus from one or more gag and pol containing constructs and the envelope of MMTV virus from the same or an independent env containing construct, and to pseudotyped retroviral particles produced by culturing said retroviral vector system transfected with a MLV based retroviral vector, and isolation of said pseudotyped retroviral particles.
摘要:
The present invention relates to the use of the WAP or MMTV regulatory sequences for the targeted expression of linked heterologous DNA sequences in human mammary cells, including human mammary carcinoma cells.